Background: Nevus of Ota (NO) is a relatively common pigmentary disorder in Asians. Tanino's classification is an old but tacit consensus to delineate the disease. Various treatment options have been presented. However, a few studies have been conducted on available laser options and current treatment strategies or the classification of NO. Objective: To investigate current laser options and their effectiveness for the treatment of NO, contributing factors to clinical outcomes, and verification of classification. Methods: A retrospective study of NO was conducted by reviewing medical charts and photographs of sixty-seven patients. Statistical analysis was used to compare excellent and poor outcomes and determine contributing factors. Results: The median age of onset was below the age of 1 (interquartile range [IQR], 0∼1). Tanino's and PUMCH classification systems failed to classify patients in 24 (35.8%) and 6 (9.0%) of patients, respectively. A 1,064 nm Q-switched Nd:YAG laser without additional lasers was used most frequently in 42 patients (62.7%). The frequency of treatment was 19.0 (IQR, 10.0∼ 23.0) in the cured group defined as subjects showing 95% improvement or above, compared to 10.0 (IQR, 6.25∼ 13.75) in the unattained group defined as subjects showing less than 95% improvement (p=0.001). Conclusion: A 1,064 nm Q-switched Nd:YAG laser is a reliable treatment armamentarium, functioning as a single infallible modality as well as a combination treatment modality for NO. Repetitive laser treatments without interruption seems to be the most suitable in clearing NO. The current classification systems of NO are defective. Thus, a new classification should be developed. 
INTRODUCTION
Nevus of Ota (NO), or oculodermal melanocytosis, affects about 0.02%∼0.8% of Asians. However, it is rarely present in white populations 1, 2 . Pathologically, it is a dermal melanocytic hamartoma that presents with unilateral or bilateral, brown or blue discoloration on the facial skin innervated by the trigeminal nerve 2, 3 . To date, a variety of treatments for this 'infamous' patch on the face have been introduced 4 . In the early phase, cryosurgery, surgical excision, skin grafting and dermabrasion are typically employed 5 . Since the development of laser technology, several lasers have been introduced into the treatment of benign pigmentary lesions. Notably, Q-switched (QS) laser systems have gained popularity in the treatment of NO as they produce less scarring and better outcomes 6 . Nonetheless, the introduction of various treatment options for NO have made it difficult for dermatologists to choose the best solution in practice. Tanino's classification has been widely accepted by dermatologists to classify NO. It was coined by Tanino in 1939, who observed several patients with NO and divided these cases into types by the extent of skin involvement 7 . Until now, many studies concerning NO were performed and discussed using Tanino's classificaition 2, 8, 9 .
However, several studies have demonstrated that Tanino's classification leaves a considerable portion of patients unexplained 10, 11 . Variants unclassified by conventional classification have been reported and therefore have revealed the weaknesses of the original version of Tanino's classifications. Several new classifications have been suggested, but have not drawn much attention yet 11, 12 . In this context, we attempted to present an overview of our experience concerning laser modalities for the treatment of NO, clinical outcomes, and factors affecting the results. In addition, we analyzed the current classification systems in a literature review. 11 . For convenience, the authors used a three-point severity scale based on the proportion of the NO on the half face as follows: mild, ≤one third of the half face; moderate, ＞one third, ≤two thirds and severe, ＞two thirds.
MATERIALS AND METHODS

Patients
Specification of laser systems
According to the physicians' personal experience, available equipment and preference, several laser modalities were used including QS neodymium-doped yttrium aluminium garnet (Nd:YAG) lasers (Spectra VRMIII TM ; Spectra Three different QS Nd:YAG laser devices were simultaneously used were considered as a single device as they had similar outcomes. Specific modes in the same laser 
RESULTS
Participant characteristics
Among the 67 enrolled patients, gender was almost equally distributed; 30 were males and 37 were females. The median age at diagnosis was 6 years (interquartile range [IQR], 2.8∼20.0). The majority of patients had documented NO that had occurred before 1 year of age.
Various colors were present on the face although blue and blue brown were slightly dominant. The median number of times that the patients visited our clinic for treatment was 11 sessions (IQR, 7∼19; Table 1 ).
Classification of NO by various methodologies
Based on the three-point severity scale, 86.6% of patients demonstrated mild and moderate severity, occupying less than two thirds of the half face ( Fig. 1 ). Tanino's classification was able to classify only 64.2% of patients. However, the PUMCH classification was able to classify 91% of patients. In other words, 18 patients who were not specified with Tanino's classification were able to be sorted by the PUMCH classification (Fig. 2) . Six (9.0%) patients remained unspecified when considering both Tanino's and the PUMCH classification ( Table 2 , Fig. 3 ).
There was no significant association between Tanino's classification, the three-point severity scale or the PUMCH classification and the frequency of an excellent outcome (p=0.295, p=0.493 and p=0.462, respectively).
Application of various lasers and other modalities 1) Lasers and parameters
In our study, the 1,064 nm Q-switched Nd:YAG laser (1,064 QSNY) was a mainstay of treatment for NO as all 67 patients were treated by a 1,064 QSNY more than PUMCH: Peking Union Medical College Hospital. *Three-point severity scale is based on the proportion of involvement of the once. Among the 10 different laser systems, the PTP mode in a 1,064 nm Nd:YAG laser and a 1,064 nm PNY were the two popular types used in combination with a 1,064 QSNY (Fig. 4) . For most of our patients, however, a 1,064 QSNY alone (62.7%) was the single most useful modality, as previously described (Table 3 ) 15, 16 .
All patients were treated with appropriate fluences and spot sizes depending on the system used: 1,064 nm QSNY at a 2-to 8-mm spot-size and 0.4∼6.0 J/cm 2 , QLNY at a 7-half-face; mild (≤1/3), moderate (＞1/3, ≤2/3), severe (＞2/3). 
2) Other modalities
For adjuvant therapy, cryotherapy and topical hydroquinone were used although only three patients (4.5%) underwent cryotherapy. There were no statistically significant differences between the cryotherapy-treated group and the others. Previously, topical hydroquinone has also been shown to not have significant benefits 6 .
Clinical outcomes
The majority of the patients demonstrated improvement (Fig. 5∼7 ): 40.3% were classified as "excellent or cured," 29.9% as "good," 16.4% as "fair," 4.5% as "poor" and 9.0% as "no change." Only two of 67 patients (3.0%) experienced persistent side effects, such as a depressed scar. 
Cured vs. unattained group
Patients were sorted into two groups based on the clinical outcomes: the cured group was defined as subjects with excellent or cured results, and the unattained group was defined as all other subjects. Between two groups, the difference in number of treatment sessions was statistically significant, and the cured group required more laser treatment sessions than the unattained group (p=0.001). The cured group (mean, 1.0) was more frequently treated with a single laser modality, such as 1,064 QSNY, compared to the unattained group (mean, 2.0) although this was not statistically significant (p=0.084). The age at the first treatment and eyelid involvement were also not significant, but the cured group was slightly younger and had less eyelid involvement compared to the other group (p=0.682 and p=0.258, respectively). There was no statistically significant difference in severity observed between the cured and unattained groups (p=0.493, Table 4 ).
DISCUSSION
A NO is composed of melanocytes distributed between the collagen fibers in the dermis 17 . Relatively little is known about the underlying mechanism of the treatment of NO with lasers. Theoretically, extremely short bursts emitted by QS lasers are absorbed by melanosomes at a sufficient energy to break down tissue with the lowest collateral thermal damage, referred to as selective photothermolysis 5 . Our study validates the usefulness of QS lasers as a single effective treatment modality for NO as the results reveal a significant improvement in patients treated with a 1,064 QSNY laser. In addition, laser treatments may not only stimulate laser-induced pigmentary destruction, but also, dermal regeneration of collagen fibers. Thus dermal fibrosis as well as the disappearance of pigmentation following laser irradiation might deter the residual pigment particles from being noticable 18 . In our study, long pulsed and quasi-long-pulsed laser systems were included as a treatment modality. Despite the small number of cases and inconsistent schedules, we expected that long pulsed lasers would work by stimulating collagen remodeling through combined mechanical and thermal effects 19 .
The IPL with a 560 nm filter also performed based on the suggested mechanism, in which diffuse epidermal necrosis occurs through energy distribution 20 . The latest 1,064 nm picosecond laser was used with expectations that the shortest pulse duration may facilitate the removal of pigmentation without lateral heat damage. The novel QS 660 nm Nd:YAG laser was thought to function similar to a conventional QS ruby laser. Lastly, an Er:YAG laser was used for only two patients as they seemed to have superficial skin changes over the NO. Notably, 18 patients (26.8%) exhibited a bumpy skin surface to varying degrees. In this regard, it is recommended that improving pigmentation as well as skin roughness should be taken into consideration in the treatment of NO. Unlike other researchers, our study included all the patients treated with Table 5 ). The possible factors that influence the results of the study were identified in the current literature: eyelid lesions, Tanino's classification, number of treatment sessions, a bilateral nevus, skin phototype, color of the lesion, and age at the first treatment 2, 6, 16, 18 . Our results revealed that the frequency of treatments was the key factor, which confirmed that more treatments would result in better outcomes, which is in agreement with other studies 2, 16 . On the other hand, no significant correlation was revealed between the presence of an eyelid lesion and the severity or classification and clinical outcomes. These results can be corroborated by Zong and Lin's finding 9 , in which Tanino's classification had no relationship with the cure rate, although Wang et al. 2 found that eyelid lesions and Tanino's classification were correlated with clinical outcomes. In addition, the present analysis did not show any significant difference between age at the first treatment and clinical results, which is not consistent with the results of our previous study 6 . It was speculated that various laser combinations without homogeneity may affect the results and attenuate significance. Also, our treatment standard was set high at 95% or above improvement, to meet the patients' and clinicians' satisfaction in a real practice 2, 6 .
For better cosmetic outcomes, various lasers were selected, but this did not lead to significant differences in outcomes in this study. Even with this slight non-alignment, the results revealed that NO is curable with consistent and repetitive laser treatment.
In most studies, transient pigmentary changes were identified, ranging from 8% to 25.1%, which were consistent with that of 15.0% in our study. Only two (3.0%) patients experienced atrophic scarring, which showed gradual improvements with time. This project was limited in that it was a retrospective and uncontrolled study, including irregular and unequal treatment intervals as well as variable parameters. Second, the recurrence rate was not able to be analyzed because long term follow-up was not feasible. Third, a small sample size may result in a lack of association with the classifications and outcomes. Lastly, skin biopsies were not performed in most of NO patients; thus, we couldn't evaluate the histopathogical aspects of NO.
Since the aforementioned shortcomings existed in this study, a long-term, controlled prospective study with a large study population is required to determine a new classification system that reflects the pathogenesis and clinical prognosis of NO and to determine the best treatment methods for NO.
Our study confirmed that a 1,064 nm QSNY is an effective modality in the treatment of NO, which can function as a single infallible as well as a combination treatment modality. Various treatment sessions are crucial in order to achieve successful and satisfactory results. Existing clinical classifications are not well suited for real-world application.
A new clinical classification system should be developed.
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